ONCOLOGY

简称 ONCOLOGY-BASEL ·SWITZERLAND ·出版周期 Bimonthly ·年均收录 97 篇

1.8

最新影响因子

1.70%

自引率

较易

投稿难度

较慢,6-12周

审稿周期

期刊简介

ONCOLOGY是一本国际知名的肿瘤学杂志，ISSN号为0030-2414，由瑞士的Karger出版社出版，出版地为巴塞尔，出版周期为月刊。该杂志的影响因子根据年份有所不同，近年大约在2-3之间，属于SCI收录期刊，中科院分区通常位于医学大类3区或4区，具体分区需参考当年中科院发布的期刊分区表。ONCOLOGY并非完全开放获取（OA）期刊，但提供部分OA选项。杂志的发文特点集中于肿瘤学领域的基础与临床研究，涵盖肿瘤生物学、诊断、治疗及预防等多个方向，尤其关注转化医学和跨学科研究。其质量较高，审稿流程严格，但影响因子相对中等，可能存在投稿竞争激烈或审稿周期较长的风险，适合有一定研究基础的学者投稿。

影响因子趋势

近期发表

Usefulness of the Lymphocyte-to-Monocyte Ratio in Predicting Prognosis in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab 2026-08-03

Practical Guide for Managing Philadelphia-Negative Myeloproliferative Neoplasms in Patients with Organ Dysfunction 2026-07-21

A Real-World Pharmacovigilance Analysis of HER2 Inhibitor-Induced Cardiovascular Toxicity 2026-07-21

Fat Mass and Survival in Immunotherapy-Treated Metastatic Renal Cell Carcinoma Patients 2026-07-16

Unique Stroma of Higher-Grade Pancreatic Intraepithelial Neoplasia: Fibroblastic Cluster Formation and CD36 Downregulation 2026-07-14

Emergency Department Visits after Radiotherapy in Patients with Solid Malignancies: Analysis of Causality and Severity 2026-07-10

Evolving Therapeutic Landscape in Non-Muscle-Invasive Bladder Cancer 2026-07-09

Hydroxyurea Bridging Before Frontline Tyrosine Kinase Inhibitor Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Critical Appraisal 2026-07-09

Real-World Outcomes in Acute Promyelocytic Leukemia: A 13-Year Cohort from Qatar 2026-07-03

SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance 2026-06-15